Correlation Between Freedom Day and Tema Oncology
Can any of the company-specific risk be diversified away by investing in both Freedom Day and Tema Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freedom Day and Tema Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Freedom Day Dividend and Tema Oncology ETF, you can compare the effects of market volatilities on Freedom Day and Tema Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freedom Day with a short position of Tema Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freedom Day and Tema Oncology.
Diversification Opportunities for Freedom Day and Tema Oncology
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Freedom and Tema is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Freedom Day Dividend and Tema Oncology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tema Oncology ETF and Freedom Day is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freedom Day Dividend are associated (or correlated) with Tema Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tema Oncology ETF has no effect on the direction of Freedom Day i.e., Freedom Day and Tema Oncology go up and down completely randomly.
Pair Corralation between Freedom Day and Tema Oncology
Given the investment horizon of 90 days Freedom Day is expected to generate 26.16 times less return on investment than Tema Oncology. But when comparing it to its historical volatility, Freedom Day Dividend is 46.58 times less risky than Tema Oncology. It trades about 0.09 of its potential returns per unit of risk. Tema Oncology ETF is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 352.00 in Tema Oncology ETF on November 9, 2024 and sell it today you would earn a total of 2,203 from holding Tema Oncology ETF or generate 625.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 75.66% |
| Values | Daily Returns |
Freedom Day Dividend vs. Tema Oncology ETF
Performance |
| Timeline |
| Freedom Day Dividend |
| Tema Oncology ETF |
Freedom Day and Tema Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Freedom Day and Tema Oncology
The main advantage of trading using opposite Freedom Day and Tema Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freedom Day position performs unexpectedly, Tema Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tema Oncology will offset losses from the drop in Tema Oncology's long position.The idea behind Freedom Day Dividend and Tema Oncology ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Tema Oncology vs. Freedom Day Dividend | Tema Oncology vs. Franklin Templeton ETF | Tema Oncology vs. iShares MSCI China | Tema Oncology vs. Tidal Trust II |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |